Evidence map›Paper›PMID 22492666›Full record

ArticleChembiochem : a European journal of chemical biology2012

Photochemical modulation of Ras-mediated signal transduction using caged farnesyltransferase inhibitors: activation by one- and two-photon excitation.

Daniel Abate-Pella, Nicholette A Zeliadt, Joshua D Ochocki, Janel K Warmka, Timothy M Dore, David A Blank, Elizabeth V Wattenberg, Mark D Distefano

Open access · greenAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Photoactivatable, biologically-relevant phenols with sensitivity toward 2-photon excitation.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2015
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel Abate-PellaDepartment of Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.
Nicholette A Zeliadt
Joshua D Ochocki
Janel K Warmka
Timothy M Dore
David A Blank
Elizabeth V Wattenberg
Mark D Distefano
University of Minnesota · USUniversity of Georgia · US

Funding

Chemistry-Biology Interface Training GrantT32GM008700 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI DISTEFANO, MARK D · 1999 to 2018
$4.0M
Negative Regulators: Key Determinants in CarcinogenesisR01CA104609 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WATTENBERG, ELIZABETH V. · 2005 to 2009
$1.1M
NCI NIH HHS CA 104609NCI NIH HHS R01 CA104609NIGMS NIH HHS GM 008700NIGMS NIH HHS GM 58442NIGMS NIH HHS T32 GM008700
6 · The paper itself

Abstract

The creation of caged molecules involves the attachment of protecting groups to biologically active compounds such as ligands, substrates and drugs that can be removed under specific conditions. Photoremovable caging groups are the most common due to their ability to be removed with high spatial and temporal resolution. Here, the synthesis and photochemistry of a caged inhibitor of protein farnesyltransferase is described. The inhibitor, FTI, was caged by alkylation of a critical thiol group with a bromohydroxycoumarin (Bhc) moiety. While Bhc is well established as a protecting group for carboxylates and phosphates, it has not been extensively used to cage sulfhydryl groups. The resulting caged molecule, Bhc-FTI, can be photolyzed with UV light to release the inhibitor that prevents Ras farnesylation, Ras membrane localization and downstream signaling. Finally, it is shown that Bhc-FTI can be uncaged by two-photon excitation to produce FTI at levels sufficient to inhibit Ras localization and alter cell morphology. Given the widespread involvement of Ras proteins in signal transduction pathways, this caged inhibitor should be useful in a plethora of studies.

Indexed as

PhotonsAnimalsCell LineCoumarinsDogsEnzyme InhibitorsFarnesyltranstransferaseHumansPhotochemical Processesras ProteinsSignal TransductionSpectrometry, FluorescenceCoumarinsEnzyme InhibitorsFarnesyltranstransferaseras Proteins

Identifiers

PMID22492666
PMCPMC3436068
OpenAlexW2050978280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.